Showing results (881-890 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|October 19, 2019
Primary ciliary dyskinesia in the genomics ageJane S Lucas, Stephanie D Davis, Heymut Omran, et al.
The Lancet. Respiratory Medicine|September 21, 2018
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trialGary T Ferguson, Klaus F Rabe, Fernando J Martinez, et al.
The Lancet. Respiratory Medicine|September 21, 2018
Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort studySimon L F Walsh, Lucio Calandriello, Mario Silva, et al.
The Lancet. Respiratory Medicine|August 5, 2018
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort studyAlexander F A D Schauwvlieghe, Bart J A Rijnders, Nele Philips, et al.
The Lancet. Respiratory Medicine|June 2, 2018
Diagnosis and management of pulmonary toxicity associated with cancer immunotherapySawsan Rashdan, John D Minna, David E Gerber
The Lancet. Respiratory Medicine|July 25, 2018
Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trialSanjeevan Muruganandan, Maree Azzopardi, Deirdre B Fitzgerald, et al.
The Lancet. Respiratory Medicine|May 20, 2017
Effect of early supplemental parenteral nutrition in the paediatric ICU: a preplanned observational study of post-randomisation treatments in the PEPaNIC trialIlse Vanhorebeek, Sascha Verbruggen, Michaël P Casaer, et al.
The Lancet. Respiratory Medicine|May 25, 2018
Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trialsReynold A Panettieri, Ulf Sjöbring, AnnaMaria Péterffy, et al.
The Lancet. Respiratory Medicine|August 31, 2016
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trialPaul M O'Byrne, Hristo Metev, Margareta Puu, et al.
The Lancet. Respiratory Medicine|April 2, 2018
Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trialPeter M A Calverley, Antonio R Anzueto, Kerstine Carter, et al.
Pageof 104